Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MSX1 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MSX1 mRNA | affects expression | 16483693
|
C007076 |
citral |
citral results in decreased expression of MSX1 mRNA | decreases expression | 15581867
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of MSX1 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of MSX1 mRNA | increases expression | 16367923
|
D004040 |
Dietary Carbohydrates |
Dietary Carbohydrates results in increased expression of MSX1 mRNA | increases expression | 17490981
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of MSX1 mRNA | increases expression | 18035473
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of MSX1 mRNA] | decreases expression|decreases reaction | 19615344
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate results in decreased expression of MSX1 mRNA | decreases expression | 19615344
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of MSX1 mRNA | increases expression | 16772331
|
C115461 |
SC 560 |
SC 560 results in decreased expression of MSX1 mRNA | decreases expression | 14633654
|
C115461 |
SC 560 |
SC 560 results in decreased expression of MSX1 protein | decreases expression | 14633654
|
C017947 |
sodium arsenite |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of MSX1 mRNA] | decreases expression|decreases reaction | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of MSX1 mRNA | decreases expression | 19615344
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of MSX1 mRNA | decreases expression | 12734198
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of MSX1 protein | decreases expression | 12734198
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MSX1 mRNA | decreases expression | 17586704 16922920
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MSX1 mRNA | increases expression | 17138961
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MSX1 mRNA | increases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.80 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.00 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.10 | 18759972 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.11 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.12 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.12 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.88 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.88 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.76 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
SC 560 |
6.76 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.76 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.76 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.46 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.67 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.67 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.67 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.78 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.78 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.95 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 15301380 12701100 12163415 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.83 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 12163415 14654219 14630905 15301380 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.46 | 9142499 14991402 10589399 9664655 16925845 9224671 17551590 9125849 9211117 8800419 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.27 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.27 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.21 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.14 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.97 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.91 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.16 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.16 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
15.16 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.76 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.95 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.95 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.62 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.62 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.20 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16959395 15340226 18606429 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.01 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.01 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.02 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.02 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.08 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.08 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.12 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.12 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.11 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.11 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.78 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.51 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.51 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.75 | 18454857 17236224 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.75 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.00 | 17679729 18206229 18460780 18704418 19387464 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.00 | 16294345 19850784 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.19 | 17649720 17301526 16823087 17217047 17294898 16331271 19642359 17506722 17361223 16766008 17712046 17368321 17339181 19029980 17107899 15748426 19075265 19225113 16788101 19035177 16891316 16935935 9834237 12679006 16140955 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.32 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.32 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.54 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.54 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.91 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.91 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.21 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.44 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.44 | 17306315 17077188 19931552 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.44 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.46 | 19470736 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.20 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.20 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.20 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.38 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.58 | 19010910 16882708 18608210 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.58 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.49 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.49 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.49 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.74 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.73 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.73 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.43 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.43 | 9142499 |
OMIM:608874 |
OROFACIAL CLEFT 5 |
marker/mechanism |
|
| |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.03 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.03 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.03 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.44 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.44 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.27 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11118676 11222880 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.80 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.29 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.15 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.15 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.57 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.57 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.57 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.84 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.56 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.56 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.43 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.43 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D014071 |
Tooth Abnormalities |
marker/mechanism |
|
| 14630905 |
OMIM:106600 |
TOOTH AGENESIS, SELECTIVE, 1 |
marker/mechanism |
|
| |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.32 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.32 | 11723127 16712894 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.58 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.58 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.72 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.16 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.16 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.51 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |
MESH:C536736 |
Witkop syndrome |
marker/mechanism |
|
| |
MESH:D054877 |
Wolf-Hirschhorn Syndrome |
marker/mechanism |
|
| 14630905 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |